HomeAgendaEU support offersContact
Register
Register
Register

Bogazici University Center for Targeted Therapy Technologies

R&D Institution

ct3.bogazici.edu.tr/İstanbul, Türkiye

About

Boğaziçi CT3 (Center for Targeted Therapy Technologies of Boğaziçi University) is a prominent research center within Boğaziçi University (Istanbul, Türkiye), focusing on innovative and high-impact research in life sciences and technologies.

The center leverages Boğaziçi University's strengths in natural and applied sciences to drive technological advancements, not only in the rapidly advancing fields of medical biotechnology, but also within a novel set of “smart” in vivo biomedical devices.

It fosters active collaborations between academia, industry, and healthcare sector with its recently updated sharp focus on targeted therapy technologies.

Established within one of nation’s leading universities, Boğaziçi University’s CT3 supports multidisciplinary research and is the national trailblazer when it comes to successful technology transfer, academic spin-off and commercialization activities from biomedical and biotechnological academic innovations.

Agriculture & Food

AgricultureNutrition and Health

Energy

Bioenergy and biofuels

Life Science, Healthcare & Cosmetics

Medical technology (Medtech)Bio Technology (Biotech)Other – Life Sciences

Services

Project DevelopmentConsulting & EngineeringOther - Services

Engineering & Technology

Other - Engineering & technology

ICT/Electronics

Micro- and Nanotechnology

Representatives

Head of Project & IP Management

Bogazici University Center for Targeted Therapy Technologies

Bogazici University Center for Targeted Therapy Technologies

Marketplace (3)

  • Project cooperation

    TOXIMIND

    Prospective Multicenter Double-Blinded Post-Mortem Brain Analysis of Heavy Metal and Micro/Nanoplastic Accumulation

    Author

    Head of Project & IP Management at Bogazici University Center for Targeted Therapy Technologies

    İstanbul, Türkiye

  • Project cooperation

    CUTIVAX

    A Subcutaneous & Tumor Resection Cavity Implantable Immunotherapy Platform

    Author

    Head of Project & IP Management at Bogazici University Center for Targeted Therapy Technologies

    İstanbul, Türkiye